Clinical Trial - Can you help?

GlaxoSmithKline Research & Development Ltd are looking for people with RA to take part in a new study, lasting up to 20 weeks to help with the development of a new potential treatment for RA.

You must be aged between 18-75, diagnosed with RA and currently experiencing symptoms, and are being treated with one conventional DMARD.

Find out more here:


You may also like...